120 related articles for article (PubMed ID: 1439645)
1. Efficacy of phosphodiesterase inhibitor enoximone in management of postcardiotomy cardiogenic shock.
Iversen S; Mayer E; Hake U; Schmiedt W; Jakob H; Oelert H
Scand J Thorac Cardiovasc Surg; 1992; 26(2):143-9. PubMed ID: 1439645
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction.
Fuhrmann JT; Schmeisser A; Schulze MR; Wunderlich C; Schoen SP; Rauwolf T; Weinbrenner C; Strasser RH
Crit Care Med; 2008 Aug; 36(8):2257-66. PubMed ID: 18664782
[TBL] [Abstract][Full Text] [Related]
3. Administration of enoximone in cardiogenic shock.
Vincent JL; Carlier E; Berré J; Armistead CW; Kahn RJ; Coussaert E; Cantraine F
Am J Cardiol; 1988 Sep; 62(7):419-23. PubMed ID: 2970777
[TBL] [Abstract][Full Text] [Related]
4. [Enoximone--clinical experiences in heart surgery].
Krüger AD; Francke A; Emmrich K
Anaesthesiol Reanim; 1996; 21(3):60-8. PubMed ID: 8766397
[TBL] [Abstract][Full Text] [Related]
5. Low-output syndrome after heart surgery: is a monotherapy with phosphodiesterase-III inhibitors feasible? A comparative study of amrinone and enoximone.
Zerkowski HR; Günnicker M; Freund U; Dieterich HA; Dressler HT; Doetsch N; Schieffer M; Hakim-Meibodi K; Lockhart JD; Reidemeister JC
Thorac Cardiovasc Surg; 1992 Dec; 40(6):371-7. PubMed ID: 1290186
[TBL] [Abstract][Full Text] [Related]
6. Conventional hemodynamic resuscitation may fail to optimize tissue perfusion: an observational study on the effects of dobutamine, enoximone, and norepinephrine in patients with acute myocardial infarction complicated by cardiogenic shock.
den Uil CA; Lagrand WK; van der Ent M; Nieman K; Struijs A; Jewbali LS; Constantinescu AA; Spronk PE; Simoons ML
PLoS One; 2014; 9(8):e103978. PubMed ID: 25084171
[TBL] [Abstract][Full Text] [Related]
7. The role of enoximone in the treatment of cardiogenic shock.
Vincent JL; Léon M; Berré J
Cardiology; 1990; 77 Suppl 3():21-6; discussion 27-33. PubMed ID: 2176130
[TBL] [Abstract][Full Text] [Related]
8. [Continuous infusion of enoximone in the treatment of acute myocardial ischemia with low output syndrome].
Sicignano A; Bellato V; Riboni A; Vesconi S
Minerva Anestesiol; 1994 Mar; 60(3):109-13. PubMed ID: 8090300
[TBL] [Abstract][Full Text] [Related]
9. Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: improvement in hemodynamic and metabolic profile.
Galie N; Branzi A; Magnani G; Melandri G; Caldarera I; Rapezzi C; Grattoni C; Magnani B
Cardiovasc Drugs Ther; 1993 Jun; 7(3):337-47. PubMed ID: 8364004
[TBL] [Abstract][Full Text] [Related]
10. Enoximone and acute left ventricular failure during weaning from mechanical ventilation after cardiac surgery.
Paulus S; Lehot JJ; Bastien O; Piriou V; George M; Estanove S
Crit Care Med; 1994 Jan; 22(1):74-80. PubMed ID: 8124979
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of enoximone in the management of refractory low-output states following cardiac surgery.
Gonzalez M; Desager JP; Jacquemart JL; Chenu P; Muller T; Installé E
J Cardiothorac Anesth; 1988 Aug; 2(4):409-18. PubMed ID: 17171924
[TBL] [Abstract][Full Text] [Related]
12. [Enoximone as an alternative to mechanical circulatory support prior to heart transplantation].
Schmid ER; Zollinger A; Turina M; Dieterich HA
Schweiz Med Wochenschr; 1989 Sep; 119(36):1231-6. PubMed ID: 2529633
[TBL] [Abstract][Full Text] [Related]
13. [Enoximone in postoperative "low-output syndrome"--comparison with dobutamine].
Orellano L; Darwisch M; Dieterich HA; Köllner V
Z Kardiol; 1991; 80 Suppl 4():53-7. PubMed ID: 1833898
[TBL] [Abstract][Full Text] [Related]
14. Addition of phosphodiesterase inhibitors to adrenergic agents in acutely ill patients.
Vincent JL; Léon M; Berré J; Mélot C; Kahn RJ
Int J Cardiol; 1990 Jul; 28 Suppl 1():S7-11. PubMed ID: 2145239
[TBL] [Abstract][Full Text] [Related]
15. Acute enoximone effect on systemic and renal hemodynamics in patients with heart failure.
Berti S; Palmieri C; Ravani M; Bonini R; Iascone MR; Clerico A; Manfredi C; Iervasi G; Ferrazzi P; Biagini A
Cardiovasc Drugs Ther; 1996 Mar; 10(1):81-7. PubMed ID: 8723174
[TBL] [Abstract][Full Text] [Related]
16. The prophylactic use of the beta-blocker esmolol in combination with phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients.
Boldt J; Brosch C; Lehmann A; Suttner S; Isgro F
Anesth Analg; 2004 Oct; 99(4):1009-1017. PubMed ID: 15385341
[TBL] [Abstract][Full Text] [Related]
17. [Enoximone in the postoperative phase of heart surgery].
Hachenberg T
Z Kardiol; 1994; 83 Suppl 2():63-8. PubMed ID: 8091826
[TBL] [Abstract][Full Text] [Related]
18. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L
J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572
[TBL] [Abstract][Full Text] [Related]
19. Addition of enoximone to adrenergic agents in the management of severe heart failure.
Vincent JL; Léon M; Berré J; Mélot C; Kahn RJ
Crit Care Med; 1992 Aug; 20(8):1102-6. PubMed ID: 1386567
[TBL] [Abstract][Full Text] [Related]
20. Enoximone therapy as pharmacological bridging to cardiac transplantation.
Park JW; Wirtz JH; May E; Mertens S; Braun P; Heinzler R; Hetzer R; Kang CS; Heinrich KW
Yonsei Med J; 1993 Mar; 34(1):63-70. PubMed ID: 8379184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
